Share on LinkedInShare on LinkedIn

ARTICLE · 19 DECEMBER 2022

Prosecution Pointer 359

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Beginning on February 1, 2023, a new program at the USPTO expedites examination for a broad scope of technologies to prevent cancer and cancer mortality, in support of President Biden's...

United StatesIntellectual Property
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Author LinkedIn connections

Beginning on February 1, 2023, a new program at the USPTO expedites examination for a broad scope of technologies to prevent cancer and cancer mortality, in support of President Biden's Cancer Moonshot. Patent applications pertaining to the qualifying technologies will be advanced out of turn for examination and will be reviewed earlier (accorded special status). The program is scheduled to run until either January 31, 2025, or the date by which the USPTO accepts a total of 1,000 grantable petitions (whichever is earlier). A link to more information can be found here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from